Anzeige
Mehr »
Login
Donnerstag, 27.03.2025 Börsentäglich über 12.000 News von 693 internationalen Medien
"Buy"-Rating und 300 % Kurspotential
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40Z8N | ISIN: US62818Q3020 | Ticker-Symbol: 2W6
NASDAQ
26.03.25
14:30 Uhr
1,490 US-Dollar
+0,080
+5,67 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
MUSTANG BIO INC Chart 1 Jahr
5-Tage-Chart
MUSTANG BIO INC 5-Tage-Chart

Aktuelle News zur MUSTANG BIO Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
05.03.Mustang Bio meets Nasdaq's equity listing requirements2
05.03.Mustang Bio regains compliance with Nasdaq Capital Market requirement2
05.03.Mustang Bio, Inc.: Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement124WALTHAM, Mass., March 05, 2025 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. ("Mustang" or the "Company") (Nasdaq: MBIO) today announced that it has received notice from The Nasdaq Stock Market LLC ("Nasdaq")...
► Artikel lesen
05.03.MUSTANG BIO, INC. - 8-K, Current Report-
28.02.Mustang Bio stock plunges 29% on lease termination news6
27.02.Mustang Bio exits Worcester facility, sells assets to AbbVie10
27.02.Mustang Bio verlässt Standort in Worcester und verkauft Vermögenswerte an AbbVie6
MUSTANG BIO Aktie jetzt für 0€ handeln
27.02.Mustang Bio, Inc.: Mustang Bio Announces Sale of Fixed Assets and Exit of Facility425WALTHAM, Mass., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. ("Mustang" or the "Company") (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs...
► Artikel lesen
21.02.MUSTANG BIO, INC. - 8-K, Current Report12
11.02.Mustang Bio regains compliance with Nasdaq minimum bid price requirement5
11.02.Mustang Bio, Inc.: Mustang Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement125WORCESTER, Mass., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. ("Mustang" or the "Company") (Nasdaq: MBIO) today announced that it has received notice from The Nasdaq Stock Market LLC ("Nasdaq")...
► Artikel lesen
11.02.MUSTANG BIO, INC. - 8-K, Current Report1
10.02.Mustang Bio, Inc.: Mustang Bio Announces Closing of $8 Million Public Offering4
06.02.Mustang Bio Prices Public Offering Of 2.65 Mln At $3.01/shr; Stock Down In Pre-market3
06.02.Mustang Bio sets terms for $8M public offering4
06.02.Mustang Bio, Inc.: Mustang Bio Announces Pricing of $8 Million Public Offering2
05.02.MUSTANG BIO, INC. - S-1/A, General form for registration of securities1
17.01.MUSTANG BIO, INC. - 8-K, Current Report8
15.01.Mustang Bio files to sell common stock, warrants6
15.01.MUSTANG BIO, INC. - S-1, General form for registration of securities1
Seite:  Weiter >>
44 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,2